# FDA 483 - OneBlood, Inc. - April 18, 2019

Source: https://www.globalkeysolutions.net/records/483/oneblood-inc/58a7444a-d23b-4763-ba9e-7556347c7bf2

> FDA 483 for OneBlood, Inc. on April 18, 2019. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: OneBlood, Inc.
- Inspection Date: 2019-04-18
- Product Type: biologics
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: An FDA inspection of OneBlood, Inc. in Pensacola, FL, a community blood center, identified a significant issue during a mobile blood drive. The firm failed to provide adequate private space for individuals to complete computer-assisted self-interviews to determine their eligibility as blood donors. This condition could compromise the accuracy and privacy of sensitive donor screening information.

## Related Officers

- [Jason D Abel](https://www.globalkeysolutions.net/people/jason-d-abel/42c4bafe-17bb-4a43-80cd-83dd77b3426d)

Company: https://www.globalkeysolutions.net/companies/oneblood-inc/ed0d4d35-e4b5-4e36-b8c5-a071e0e34864

Office: https://www.globalkeysolutions.net/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6